Canaccord Genuity Group Issues Pessimistic Forecast for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPN - Free Report) had its price objective decreased by Canaccord Genuity Group from $20.00 to $15.00 in a research note released on Friday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the construction company's stock.

Other equities analysts have also recently issued research reports about the company. Roth Mkm cut their price target on Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a report on Friday, November 8th. Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a research note on Tuesday, October 22nd. StockNews.com raised Aspen Aerogels to a "sell" rating in a research note on Saturday, February 8th. Craig Hallum lowered their price objective on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research note on Friday. Finally, Seaport Res Ptn lowered Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. One analyst has rated the stock with a sell rating, one has issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $24.67.

Aspen Aerogels Price Performance

NYSE ASPN traded down $0.09 during trading on Friday, hitting $8.55. 2,796,169 shares of the stock traded hands, compared to its average volume of 2,151,431. The company has a market capitalization of $701.12 million, a P/E ratio of 855.36 and a beta of 2.14. The firm has a 50-day simple moving average of $12.06 and a 200-day simple moving average of $18.36. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels has a 12-month low of $8.25 and a 12-month high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. As a group, analysts predict that Aspen Aerogels will post 0.12 EPS for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently modified their holdings of the business. nVerses Capital LLC lifted its stake in shares of Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company's stock worth $161,000 after acquiring an additional 1,800 shares during the last quarter. Quest Partners LLC lifted its stake in shares of Aspen Aerogels by 263.3% during the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company's stock worth $205,000 after acquiring an additional 5,361 shares during the last quarter. Sandia Investment Management LP bought a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $89,000. Pursue Wealth Partners LLC bought a new stake in shares of Aspen Aerogels during the 3rd quarter worth approximately $222,000. Finally, Mesirow Financial Investment Management Inc. bought a new stake in shares of Aspen Aerogels during the 3rd quarter worth approximately $252,000. 97.64% of the stock is owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.